What will drug development look like aboard a new commercial space station?

Medicare publishes policy for amyloid mAbs and Alzheimer’s disease. It’s not good news for Aduhelm.

How an initiative from EFPIA and a new public database on chemical substances could reduce animal experiments.

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

We find out how technology is enabling remote inspections in the pharma industry.

How pharmaceutical therapeutics are expanding into a whole new galaxy of options.

What is going on with Aduhelm? And why is the drug seen by some to be controversial?

Get ready for medicine making level 2 as video games come to healthcare backed with clinical trial data that demonstrate efficacy.

Researchers explain how they used video games to explore human behavior when it comes to producing pharma products.

Enter the world of immersive therapeutics – where VR is being explored as an alternative to traditional medicines for pain.